Navigation Links
ProGenTech Limited Appoints Executive Management Team
Date:4/17/2008

EMERYVILLE, Calif., April 17 /PRNewswire/ -- ProGenTech, a life sciences company based in Shanghai, China and Emeryville, CA is please to announce that it has made several executive management appointments to build out its global senior management team.

Dr. Paul Richardson has joined ProGenTech as its Vice President for R&D based in Emeryville, CA. Dr. Richardson will lead the global R&D programs and have accountability for the company's assay development and reagent solutions. Dr. Richardson was previously the head of R&D at the DOE's Joint Genome Institute where for the past ten years he had led the advanced research teams supporting the human genome project as well as the microbial genome initiatives and other model organism programs. Dr. Richardson brings a wealth of life science knowledge to the company.

Dr. Jesus Ching has been appointed the Chief Scientist for ProGenTech and will be based in Emeryville, CA. Dr. Ching was a founder of ProGenTech and has been instrumental in the design and development in the products to date. Dr. Ching will have accountability for the external scientific programs as well as our technical lead on business development activities. Dr. Ching was previously the director of R&D at Cepheid and brings deep knowledge and experience in integrated systems and diagnostic platforms.

Sarah Wenning has joined ProGenTech as its Vice President of US operations, based in Emeryville CA. Ms. Wenning will have accountability for all US programs. She was previously the deputy associate director for operations of Lawrence Livermore National Laboratory's Biosciences Directorate and has held a number of senior management roles within Lawrence Livermore for the past ten years. Sarah brings significant operational expertise to the company.

Dylan Bird has joined ProGenTech as its Director of Business Development, based in Emeryville, CA. Mr. Bird will have accountability for global strategy and business development activities. Prior to joining ProGenTech, Mr. Bird was an investment professional at Bay City Capital, one of the two VC's that were part of the recently announced Series C financing.

David Hu has joined ProGenTech as its Vice President of Engineering, based in Shanghai. Mr Hu will have accountability for all engineering programs and new system development and commercialization. David will work closely with Paul Richardson to define our new product roadmaps. David was the lead Angel investor for ProGenTech and remains a member of the ProGenTech board. David has made a career as an entrepreneur and has successfully started, capitalized and sold several businesses in the consumer electronics field.

Commenting on the new team, Dr Trevor Hawkins, ProGenTech Chairman and CEO said "we have built a first class team that truly understands this market and most importantly our customers. We now have deep experience in life sciences, clinical diagnostics and systems engineering." Steve Yu, ProGenTech President and COO said "with the additional executive members coming on board, ProGenTech is now well positioned to penetrate the life science and molecular diagnostic market with our leading technologies"

About ProGenTech

ProGenTech is a life science company based in Shanghai, Suzhou and Emeryville California.

Established in 2005, the company has 40 employees today. Their first product, the Entura, was launched in Asia in November 2007. Additional information about ProGenTech can be found at http://www.progentech.com.


'/>"/>
SOURCE ProGenTech Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ProGenTech Completes $21 Million Series C Financing
2. Routinely used diagnostic approaches: only limited diagnostic sensitivity for bile duct cancer?
3. Treatment Combo for Pancreatic Cancer Has Limited Benefit
4. Lumping different countries together -- why the 2008 EPI is of limited use
5. Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named VEGO Power Blocker
6. Gap Launches Limited Edition Gap (PRODUCT) RED(TM) Mulberry Bag for Valentines Day
7. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
8. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
9. Maintenance Software Company Bucks Trend, Offers Unlimited No-Charge Product Tech Support
10. Testosterone supplementation for older men appears to have limited benefit
11. Full-Service Community Hospitals Blast Misleading Letter to Candidates From Limited-Service Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 23, 2017 , ... Old School Labs™, makers of the wildly popular all-natural ... Breon Ansley to its growing team of brand ambassadors. The Olympia top finisher and ... less than a year was able to turn professional, participating in the 2013 NPC ...
(Date:1/23/2017)... ... , ... “Crossing the Bar”: a moving and eloquent drama depicting the ... Bar” is the creation of published author, Charlotte Hotte, a North Carolina native, a ... inspiration of the book to her sister, Denise, wishes to acknowledge her savior, Jesus ...
(Date:1/23/2017)... ... ... Valentine’s Day is a time when many people celebrate romance and love by giving cards, ... for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day ... $200 and get $50 free. , “A lot of people just buy the more ...
(Date:1/22/2017)... ... ... Medical lab testing through hospitals and other traditional methods can be ... days to arrive to the end customer, having to travel through medical records and ... bypassing the cost and delay of traditional means. Now all employees of the Frisco ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats in ... its owner and founder. As Oat is recognized globally as one of the healthiest ... as he believes it is a move to sow the seed of good karma. ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... Research and Markets has announced the addition of the ... (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, ... HIV/AIDS etc.), Forecast to 2022" report to their offering. ... US ... clinical lab testing, which has evolved as a major source ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, ... Symposia Conference, "PI3K Pathways in Immunology, Growth ... (NASDAQ: INFI ) presented ... development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). ... to help overcome resistance to checkpoint inhibition ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company ... ... Hearing Aids Market Sales Volume, Company Analysis and Forecast to ... aid industry. The growing prevalence of hearing impairment ...
Breaking Medicine Technology: